{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:16:05Z","timestamp":1774894565663,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,20]]},"DOI":"10.4103\/0366-6999.238134","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T07:37:58Z","timestamp":1533022678000},"page":"1891-1893","source":"Crossref","is-referenced-by-count":8,"title":["Bronchiectasis Management in China, What We Can Learn from European Respiratory Society Guidelines"],"prefix":"10.1097","volume":"131","author":[{"given":"Ning","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Ming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Fu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-1-20210129","first-page":"379","article-title":"The prevalence and risk factors of bronchiectasis in residents aged 40 years old and above in seven cities in China (in Chinese)","volume":"52","author":"Zhou","year":"2013","journal-title":"Chin J Intern Med"},{"key":"R3-1-20210129","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/resp.12528","article-title":"Aetiology of bronchiectasis in Guangzhou, Southern China","volume":"20","author":"Guan","year":"2015","journal-title":"Respirology"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/resp.12574","article-title":"Aetiology and clinical characteristics of patients with bronchiectasis in a Chinese Han population: A prospective study","volume":"20","author":"Qi","year":"2015","journal-title":"Respirology"},{"key":"R5-1-20210129","first-page":"8","article-title":"Present situation and challenges of bronchiectasis in China (in Chinese)","volume":"40","author":"Xu","year":"2017","journal-title":"Chin J Tubere Respir Dis"},{"key":"R6-1-20210129","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1513\/AnnalsATS.201511-740PS","article-title":"Bronchiectasis in China","volume":"13","author":"Lin","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"R7-1-20210129","first-page":"301","article-title":"Clinical analysis of non-tuberculous mycobacterial pulmonary infection in patients with bronchiectasis (in Chinese)","volume":"37","author":"Xu","year":"2014","journal-title":"Chin J Tuberc Respiratiory Dis"},{"key":"R9-1-20210129","first-page":"24","article-title":"Study on the effect and predictive to bronchiectasis combined with rheumatoid arthritis (in Chinese)","volume":"40","author":"Ding","year":"2017","journal-title":"Chin J Tubere Respir Dis"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1038\/srep10961","article-title":"The existence of bronchiectasis predicts worse prognosis in patients with COPD","volume":"5","author":"Mao","year":"2015","journal-title":"Sci Rep"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1183\/13993003.01862-2015","article-title":"Asthma and bronchiectasis exacerbation","volume":"47","author":"Mao","year":"2016","journal-title":"Eur Respir J"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"e0137348","DOI":"10.1371\/journal.pone.0137348","article-title":"Impacts of co-existing chronic rhinosinusitis on disease severity and risks of exacerbations in Chinese adults with bronchiectasis","volume":"10","author":"Guan","year":"2015","journal-title":"PLoS One"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.4103\/0366-6999.167360","article-title":"Distribution of major pathogens from sputum and bronchoalveolar lavage fluid in patients with noncystic fibrosis bronchiectasis: A Systematic review","volume":"128","author":"Miao","year":"2015","journal-title":"Chin Med J"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"e014613","DOI":"10.1136\/bmjopen-2016-014613","article-title":"Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: A retrospective study","volume":"8","author":"Wang","year":"2018","journal-title":"BMJ Open"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/crj.12278","article-title":"Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: A meta-analysis","volume":"10","author":"Yang","year":"2016","journal-title":"Clin Respir J"},{"key":"R16-1-20210129","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cct.2017.05.007","article-title":"The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of ciprofloxacin dry powder for inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis","volume":"58","author":"Aksamit","year":"2017","journal-title":"Contemp Clin Trials"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijpharm.2018.06.017","article-title":"A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart","volume":"547","author":"Tran","year":"2018","journal-title":"Int J Pharm"},{"key":"R18-1-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/13543784.2018.1439919","article-title":"Inhaled medication therapy for bronchiectasis: Status quo and the next frontier","volume":"27","author":"Chen","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"R19-1-20210129","first-page":"CD012579","article-title":"Oral versus inhaled antibiotics for bronchiectasis","volume":"3","author":"Spencer","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-1-20210129","doi-asserted-by":"crossref","first-page":"L677","DOI":"10.1152\/ajplung.00123.2017","article-title":"Macrolides protect against Pseudomonas aeruginosa infection via inhibition of inflammasomes","volume":"313","author":"Fan","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R21-1-20210129","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12879-015-0872-5","article-title":"Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: A meta-analysis of randomized controlled trials","volume":"15","author":"Fan","year":"2015","journal-title":"BMC Infect Dis"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.238134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:48:35Z","timestamp":1623959315000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201808200-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":19,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.238134","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,20]]}}}